12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the performance of 12 health care stocks during Thursday's after-market session. Vaxart (VXRT) saw the highest gain with a 146.7% increase, while Alzamend Neuro (ALZN) experienced the largest decline at 24.9%.
June 13, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Kintara Therapeutics shares rose 5.82% to $0.2, increasing its market cap to $10.9 million.
The rise in Kintara Therapeutics' stock price suggests positive market sentiment and potential for short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Soligenix stock rose 5.42% to $4.38, increasing its market cap to $4.3 million.
The rise in Soligenix's stock price suggests positive market sentiment and potential for short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Venus Concept stock rose 10.32% to $0.95, increasing its market cap to $6.0 million.
The rise in Venus Concept's stock price suggests positive market sentiment and potential for short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Vincerx Pharma stock moved upwards by 5.99% to $0.73, with a market cap of $21.5 million.
The upward movement in Vincerx Pharma's stock price indicates a positive outlook in the short term.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Vaxart shares increased by 146.7% to $1.85, significantly boosting its market value to $327.1 million.
The substantial increase in Vaxart's share price indicates strong positive sentiment and potential future gains.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Beyond Air shares moved upwards by 5.64% to $1.31, with a market cap of $60.1 million.
The upward movement in Beyond Air's stock price indicates a positive outlook in the short term.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Alzamend Neuro stock declined by 24.9% to $0.43, reducing its market cap to $3.1 million.
The significant decline in Alzamend Neuro's stock price indicates strong negative sentiment and potential future losses.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Bionomics shares declined by 7.99% to $0.76, reducing its market cap to $8.1 million.
The decline in Bionomics' stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Conduit Pharmaceuticals shares fell 8.42% to $1.85, reducing its market cap to $136.5 million.
The decline in Conduit Pharmaceuticals' stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Nexalin Technology stock declined by 16.67% to $1.15, reducing its market cap to $8.5 million.
The decline in Nexalin Technology's stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
PAVmed stock fell 8.11% to $1.02, reducing its market cap to $9.6 million.
The decline in PAVmed's stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Rezolute shares declined by 15.7% to $4.35, reducing its market cap to $174.5 million.
The decline in Rezolute's stock price suggests negative market sentiment and potential for short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80